Animal Antibiotics and Antimicrobials Market Size | 2032

Report Description

Animal Antibiotics and Antimicrobials Market Outlook 2032

The global animal antibiotics and antimicrobials market size was USD 5.2 Billion in 2023 and is projected to reach USD 10.31 Billion by 2032, expanding at a CAGR of 7.9% during 2024–2032. The market growth is attributed to the rising concerns about animal health and welfare.

Increasing awareness of animal health and welfare leads to a growing demand for animal antibiotics and antimicrobials, which further boosts the market. These products play a significant role in livestock farming, companion animal healthcare, and aquaculture.  Moreover, the growing consumer base for animal-derived food products and rising pet ownership propels the demand for animal antibiotics and antimicrobials.

• According to the report published on January 25, 2024, around 66% of households in the US, which means 86.9 million homes, own a pet as of 2024. Moreover, the ownership of pets has significantly increased over the last thirty years. In 1988, only 56% of households in the United States owned a pet.
  

  Get Free Sample Report
  

Impact of Artificial Intelligence (AI) on the Animal Antibiotics and Antimicrobials Market

The emergence of artificial intelligence is likely to boost the animal antibiotics and antimicrobials market. AI-powered technologies such as machine learning algorithms and predictive analytics enable stakeholders to analyze vast datasets, identify patterns, and make data-driven decisions in real-time. Moreover, AI-driven solutions empower veterinarians and livestock producers to monitor animal health parameters, detect diseases early, and implement proactive interventions to prevent outbreaks and minimize antibiotic usage.

Animal Antibiotics and Antimicrobials Market Dynamics

Get Free Sample Report

Major Drivers

Increasing meat consumption across the globe is anticipated to drive the market during the forecast period. The preference for protein-rich diets has increased, particularly in emerging economies. This trend is expected to continue in the coming years, thereby increasing the usage of antibiotics and antimicrobials to maintain animal health and productivity in livestock farming. Additionally, the intensification of animal farming practices, especially in poultry and swine farms, boosts the demand for antimicrobials to prevent and control diseases.

• As per the report published by the US Poultry & Egg Association, the production of broilers in 2022 reached 9.17 billion, with a total live weight of 59.3 billion pounds, which is slightly higher than in 2021.

Existing Restraints

Increasing consumer awareness and preference for antibiotic-free animal products are expected to hamper the market. The demand for organic and antibiotic-free meat, poultry, and dairy products is rising among health-conscious consumers, which restrains the market. Moreover, the stringent regulations and bans on the use of antibiotics in livestock farming are expected to decrease the demand for animal antibiotics and antimicrobials during the forecast period.

Emerging Opportunities

Rising adoption of precision medicine and personalized healthcare approaches in animal husbandry is creating favorable opportunities for the players competing in the market. Manufacturers are focusing on advancing genomic technologies, data analytics, and diagnostic tools to develop precision livestock farming antibiotics and antimicrobials to optimize animal health and productivity. Moreover, the high demand for novel antibiotics and antimicrobial agents with improved efficacy and safety profiles fuels the market.

Scope of the Animal Antibiotics and Antimicrobials Market Report

The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.

Animal Antibiotics and Antimicrobials Market Segment Insights

Product Segment Analysis

Based on product, the market is divided into aminoglycosides, cephalosporins, fluoroquinolones, lincosamides, macrolides, penicillins, sulfonamides, tetracyclines, and others. The tetracyclines segment held a major share of the market in 2023, as they are widely used in animal husbandry for their broad-spectrum activity against a variety of bacterial pathogens. The versatility and efficacy of tetracyclines across different animal species, including poultry, swine, and cattle, contributed to their growing demand. Additionally, the low cost and availability of tetracycline-based antibiotics have further fueled the segment.

The fluoroquinolones segment is expected to expand at a significant growth rate in the coming years owing to the increasing prevalence of antimicrobial-resistant bacteria. Moreover, advancements in veterinary diagnostics and disease surveillance techniques have led to improved detection and management of bacterial infections in livestock. This, in turn, drives the demand for effective antimicrobial therapies, including fluoroquinolones, thereby boosting the segment.

Get Free Sample Report

Mode of delivery Segment Analysis

On the basis of mode of delivery, the global market is segregated into premixes, oral solution, oral powder, injection, and others. The injection segment held a large market share in 2023 due to its accurate dose benefits and high bioavailability of antimicrobial agents.

Injectable antibiotics are commonly used for the treatment of severe bacterial infections, including respiratory diseases, mastitis, and septicemia. Moreover, the convenience and efficacy of injection-based delivery methods have propelled their demand, thus fueling the segment.

The premixes segment is anticipated to expand at a substantial CAGR during the forecast period owing to the convenient and efficient mode of delivery for disease prevention and growth promotion in livestock. Premixes are widely used in animal nutrition programs to ensure uniform distribution of antimicrobial agents and precise dosing to optimize health outcomes and production efficiency. Additionally, advancements in feed technology and manufacturing processes have enabled the development of innovative premix formulations with enhanced stability and bioavailability, which propels the segment.

Animal Type Segment Analysis

Based on animal type, the animal antibiotics and antimicrobials market is segmented into companion animals and food-producing animals. The food-producing animals segment is projected to register a robust growth rate during the assessment years due to the rising demand for animal protein across the globe. Population growth and increasing per capita meat consumption contribute to the segmental growth. Furthermore, the globalization of food supply chains and the expansion of international trade in animal products boost the need for antimicrobial and antimicrobial products.

Get Free Sample Report

Regional Outlook

In terms of region, the global animal antibiotics and antimicrobials market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a major market share in 2023 and the market in the region is expected to grow rapidly during the projection period due to the growing demand for affordable and lean protein sources.

Consumers are increasingly prioritizing health-conscious dietary choices and the demand for protein-rich foods, including poultry, pork meat, and dairy products surged across the region. This demand necessitates the utilization of antibiotics and antimicrobials to maximize the production of these livestock.  Moreover, the dietary shifts toward protein-rich foods are further boosting the market in this region.

Asia Pacific is projected to dominate the market in the coming years owing to the increasing population and rising demand for meat and seafood. This, in turn, drives expansion in animal husbandry, which leads to increased usage of antibiotics and antimicrobials for disease prevention and treatment. Additionally, growing consumer awareness about food safety and quality and rising poultry farming in the region boost the demand for animal antibiotics and antimicrobials, thereby propelling the market.

Get Free Sample Report